CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS
Report
- Report Number
- 2017233-2017-00575
- Event Type
- Death
- Date Received
- November 1, 2017
- Date of Event
- October 11, 2017
- Report Date
- October 11, 2017
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P040043
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- PHYSICIAN
Narratives
UDI: (B)(4). CONCOMITANT PRODUCT(S): AS GORE WAS UNABLE TO DETERMINE WHICH DEVICE WAS INVOLVED IN THE EVENT IF ANY; ADDITIONAL DEVICE(S) IMPLANTED INCLUDE: TGU404020/15761281. PATIENT MEDICATIONS INCLUDE BUT ARE NOT LIMITED TO: ASPIRIN, CLONIDINE, COLACE, DOXAZOSIN, FERROUS SULFATE, FUROSEDMIDE, LEVOTHYROXINE, METOPROLOL TARTRATE, MYCOPHENOLATE MOFETIL NIFEDICAL XL, NITROGLYCERIN, OMEPRAZOLE, PLAVIX, PREDNISONE, PRAVASTATIN, PROCTO-MED HC, VICODIN, VITAMIN D3, XANAX A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE(S) VERIFIED THAT THE LOT(S) MET ALL PRE-RELEASE SPECIFICATIONS. ACCORDING TO THE INSTRUCTIONS FOR USE (IFU) FOR THE GORE® TAG® THORACIC ENDOPROSTHESIS; ADVERSE EVENTS THAT MAY OCCUR INCLUDE, BUT ARE NOT LIMITED TO INCLUDE: DEATH.
ON (B)(6) 2017, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A TYPE B THORACIC AORTIC DISSECTION WHICH ORIGINATED IN THE AORTIC ARCH (ZONE 2) AND EXTENDED DISTALLY TO THE FEMORAL ARTERY. THE PATIENT WAS IMPLANTED WITH TWO CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES USING A GORE® DRY SEAL FLEX INTRODUCER SHEATH (B)(4). IT WAS REPORTED THAT THE PATIENT EXPIRED INTRAPROCEDURE WITH THE CAUSE OF DEATH UNKNOWN, HOWEVER A POSSIBLE AORTIC RUPTURE IS SUSPECTED. NO AUTOPSY WILL BE PERFORMED. THERE WERE NO DEVICE OR SHEATH REPORTED DIFFICULTIES DURING THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 772889 | CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | 14875388A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 70 YR | Death |